IDX
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Integral Diagnostics Limited is a provider of medical diagnostic imaging services in Australia and New Zealand. The company operates a network of clinics offering non-invasive imaging technologies, including Magnetic Resonance Imaging (MRI), Nuclear Medicine, Positron Emission Tomography (PET), Computed Tomography (CT), Mammography, Ultrasound, and Radiography. Its services are delivered to general practitioners, dental practitioners, medical specialists, allied health professionals, and their patients across all Australian states and New Zealand. The company operates through various regional brands, including Capital Radiology, FMIG, Lake Imaging, The X-Ray Group, Imaging @ Olympic Park, Imaging Queensland, South Coast Radiology, Apex Radiology, Radiology Tasmania, Women's Imaging, Fowler Simmons Radiology, Astra Radiology, SRG Radiology, Trinity MRI, and Horizon Radiology. Integral Diagnostics also provides teleradiology services under the IDXt brand, supporting private practices and public hospitals with urgent, routine, and overflow reporting across all modalities.

Summarised from the company's own disclosures, fiscal year ended Jun 2026

Industry Health Care Equipment & Services Homepage integraldiagnostics.com.au
Sector Healthcare IR page integraldiagnostics.com.au/investors
Tags
diagnostic imaging, radiology, mri, ct, mammography, ultrasound, nuclear medicine, teleradiology, musculoskeletal imaging, oncology imaging, breast imaging, neuro-radiology, Capital Radiology, FMIG, Lake Imaging, The X-Ray Group, Imaging @ Olympic Park, Imaging Queensland, South Coast Radiology, Apex Radiology, Radiology Tasmania, Women's Imaging, Fowler Simmons Radiology, Astra Radiology, SRG Radiology, Trinity MRI, Horizon Radiology, IDXt
Press page —

Metrics

Valuation  
Market cap A$ 635.285M
Market cap (USD) $ 431.064M
P/E 29.28
PEG —
P/BV 0.95
P/S 1.54
P/OCF 9.60
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 3.2%
ROI 2.2%
ROIC 2.2%
Profit margin 2.8%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -4.2%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity 50.3%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 23.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Revenue 788.619M 569.286M 411.823M 440.762M 360.93M 350.696M 275.566M 232.393M 189.399M 179.732M 167.77M 151.213M
Net profit 22.04M 4.819M -60.699M 25.04M 14.603M 31.268M 23.033M 20.983M 15.079M 15.48M 11.388M 4.805M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015
Share price 2 2.54 2.67 3.28 3.03 — — — — — — —
Price performance 12m -0.21 -0.05 -0.19 0.08 — — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Correction to App3Y - Andy Fay NED Bull 0 Bear 0 Routine
Change in substantial holding Bull 0 Bear 0 Routine

Prompts

Integral Diagnostics Limited (ticker IDX), listed in Australia.

ETFs Holding Integral Diagnostics Limited

ETF Weight in ETF Shares Market value As of
DISV 0.03% 1,444,179 $ 1.672M Nov 12, 2026
DFIS 0.01% 702,161 $ 812.891K Nov 12, 2026
DXIV 0.01% 14,453 $ 16.732K Nov 12, 2026
DFSI 0.00% 24,208 $ 28.026K Nov 12, 2026
DFIC 0.00% 308,603 $ 357.269K Nov 12, 2026
DFAX 0.00% 218,652 $ 253.133K Nov 12, 2026
DFAI 0.00% 281,345 $ 325.713K Nov 12, 2026